PEA (Phenylethylamine).
The love molecule. Chocolate's mood boost in pure form.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- MoodEnergyFocus
What PEA (Phenylethylamine) is, and what it does.
- Does it work
- Suits people who want a short lift before training and are fine with it fading inside the hour. Anyone on a monoamine oxidase inhibiting medicine should ask their prescriber first.
- How much to take
- Start with 100mg a day, with 500mg the top of the daily band. Because it clears fast, when you take it matters as much as how much.
- Time to feel it
- Fast. Anything noticeable arrives within about 15 to 30 minutes of an empty-stomach dose and fades inside the hour, because monoamine oxidase B clears it quickly.
- The first dose
- A dose lands within the hour and fades inside it too. Nothing accumulates overnight, so day one shows you most of what this one does.
- With regular use
- Most effects take 2-8 weeks. Be patient.
- How well tolerated
- Generally well tolerated. Check with your doctor if on medications.
- How it feels
- Quick mood lift, energy spike. Gone fast.
- The overlooked benefit
- Your body already makes it from phenylalanine, and how much you excrete rises after hard exercise. A long run and a square of dark chocolate share a chemical signature.
100 to 500mg a day is where PEA (Phenylethylamine) works.
Source: Irsfeld et al., 2013, RSC Adv
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 10 human trials with 50% consistency.
- short-lived mood liftNarrative review
- trace amine-associated receptor 1 signallingIn vitro study
- dopamine and noradrenaline release from presynaptic terminalsAnimal study
Questions people ask about PEA (Phenylethylamine).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Phenylethylamine is formed by decarboxylating phenylalanine. Supplying the amino acid feeds the body's own production of the trace amine.
The L portion of DLPA is decarboxylated to phenylethylamine. Half the dose feeds the same one step conversion.
The decarboxylase that turns phenylalanine into phenylethylamine runs on pyridoxal phosphate. B6 status governs how much is made endogenously.
Tyrosine supplies dopamine while phenylethylamine acts as a trace amine that modulates catecholamine release. The two sit on branches of one aromatic amino acid tree.
Caffeine antagonises adenosine receptors and phenylethylamine acts on trace amine-associated receptors and promotes catecholamine release, so the two arrive at similar territory from different directions. Stacking them may add to heart rate and blood pressure responses relative to either alone, particularly in people sensitive to stimulants. The combination is common in pre-workout products and the additive load is the point to watch.
MAO-B carries a covalently bound FAD cofactor derived from riboflavin, and MAO-B is the enzyme that clears phenylethylamine within minutes of absorption. Riboflavin status therefore sits upstream of how fast the amine is degraded. This is cofactor biochemistry and does not mean riboflavin measurably shortens a dose in people.
Semicarbazide-sensitive amine oxidase and related copper amine oxidases oxidise primary amines to aldehydes, forming part of the clearance route for phenylethylamine outside the central nervous system. Copper is the catalytic metal in those enzymes. The relationship describes degradation, not potentiation.
AADC decarboxylates 5-HTP to serotonin and phenylalanine to phenylethylamine, so the two draw on one enzyme and one pyridoxal-5-phosphate pool. Loading one substrate heavily can occupy enzyme capacity that the other would use. The effect is substrate competition at a shared enzyme, not an interaction anyone has quantified in supplement doses.
Tryptophan, phenylalanine and tyrosine all cross the blood-brain barrier on LAT1, so a large dose of one lowers the fraction of the carrier available to the others. They then converge on aromatic L-amino acid decarboxylase. Timing doses apart avoids the competition, which is textbook rather than trial-derived.
Theanine is used alongside stimulants to blunt the jittery edge, and the same rationale is applied to phenylethylamine-containing pre-workouts. Theanine influences glutamate and GABA signalling rather than the trace amine system. The pairing is a formulation convention with a plausible mechanism, not a tested combination for this amine specifically.
Alpha-GPC supplies choline for acetylcholine synthesis while phenylethylamine acts on the monoamine side, so blends pair them to cover two neurotransmitter systems. The two do not share a pathway. This is a formulation logic that has not been tested as a combination.
Anything that slows monoamine oxidase raises and prolongs phenylethylamine exposure, because MAO-B clearance is what keeps the amine short-acting. Combining a MAO-affecting botanical with a monoamine substrate is a recognised caution in pharmacology, including for blood pressure. This is a flag rather than a recommendation to combine.
Magnesium status influences catecholamine handling and smooth muscle tone, which is the same territory a stimulant amine acts on. Products pairing them are aiming at the tolerability side rather than at potency. The rationale is physiological and not demonstrated for this pairing.
Ascorbate is the electron donor for dopamine beta-hydroxylase, the step that converts dopamine to noradrenaline, and phenylethylamine acts partly by promoting catecholamine release. Adequate ascorbate is therefore a background condition for that pathway. It is upstream biochemistry, not a potentiating pairing.
Talk to a doctor before taking PEA (Phenylethylamine) if any of these apply to you: maoi conflict, bp caution, stimulant. These are flags to check first, not effects PEA (Phenylethylamine) is known to cause.
Not medical advice. Show the label to your pharmacist.What PEA (Phenylethylamine) actually does.
Phenylethylamine is formed in the body by aromatic L-amino acid decarboxylase acting on L-phenylalanine, a pyridoxal-5-phosphate dependent decarboxylation.
Monoamine oxidase B degrades phenylethylamine rapidly, which is why endogenous concentrations are low and an oral dose has a very short duration of action.
Phenylethylamine is an agonist at trace amine-associated receptor 1, a G protein-coupled receptor expressed on monoaminergic neurons.
Phenylethylamine promotes release of dopamine and noradrenaline from presynaptic terminals and interacts with the monoamine transporters, which is the basis for describing it as an endogenous amphetamine-like trace amine.
Where PEA (Phenylethylamine) comes from.
The powder in a tub is made in a factory from basic chemical building blocks, then turned into a salt so it stays a dry stable solid instead of a smelly oil. Cocoa and some algae contain the same molecule naturally, but only in small and inconsistent amounts. Your own body makes it from the amino acid phenylalanine as well.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Industrial routes start from simple aromatic petrochemical intermediates rather than from a biological source.
Benzaldehyde condenses with nitromethane under base catalysis to give beta-nitrostyrene, the classic intermediate for this amine.
The nitroalkene is reduced, typically by catalytic hydrogenation or a metal hydride, to give phenylethylamine free base. The alternative route reduces phenylacetonitrile directly.
The volatile oily amine is fractionally distilled under reduced pressure to separate it from unreacted intermediates and over-reduced by-products.
The distilled base is treated with hydrochloric or citric acid in solvent to precipitate the hydrochloride or citrate as a stable handleable solid.
The salt is dried, milled and packed under low humidity because the hydrochloride draws water from air.
Getting PEA (Phenylethylamine) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- The supplementation study of a Klamath algae extract names phenylethylamine among the extract's constituents and reports outcomes for the whole extract, so it is a mentions-only source and does not isolate phenylethylamine.Open-label trial. Cremonte et al., 2017 (Journal of Medicinal Food). PMID 29116873 ↗
These are the studies our verdict leans on, chosen from the 1 we read for PEA (Phenylethylamine). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.